Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).

  • Jana Lizrova Preiningerova, Ulf Baumhackl, +27 authors Thomas Berger
  • Published 2013 in CNS neuroscience & therapeutics

Abstract

Prolonged-release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary of data on fampridine PR and recommendations on practical… (More)
DOI: 10.1111/cns.12101

Cite this paper

@article{Preiningerova2013RecommendationsFT, title={Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).}, author={Jana Lizrova Preiningerova and Ulf Baumhackl and Tunde Csepany and Adam Czapliński and F Deisenhammer and Tobias J Derfuss and Tanja Hojs Fabjan and Franz Fazekas and Siegrid Fuchs and Eva Kubala Havrdov{\'a} and Alenka Horvath Ledinek and Z Illes and Sasa Sega Jazbec and Eleon{\'o}ra Kl{\'i}mov{\'a} and S{\'a}muel Komoly and Egon Kur{\vc}a and Michael Linnebank and Lubomir Lisy and Jan Mare{\vs} and Lubica Prochazkova and Rozsa Csilla and Jarmila Szilasiov{\'a} and Pavel Stoura{\vc} and R. S. Talab and Peter Tur{\vc}{\'a}ni and Marta V{\'a}chov{\'a} and L{\'a}szl{\'o} V{\'e}csei and David Bozidar Vodusek and Olga Zapletalov{\'a} and Thomas Berger}, journal={CNS neuroscience & therapeutics}, year={2013}, volume={19 5}, pages={302-6} }